Enterome Collaborates With AbbVie on Microbiome Dx for Crohn's Disease | GenomeWeb

NEW YORK (GenomeWeb) – Enterome Bioscience today announced a collaboration with drug developer AbbVie to create molecular diagnostic tools to monitor the gut microbiome in patients with Crohn's disease and other microbiome-related diseases.

The firms will first collaborate on non-invasive microbiome monitoring tools built with Enterome's proprietary metagenomic biomarker portfolio and technologies, which the aim of improving treatment decisions in managing Crohn's disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.